The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer

OBJECTIVE: Combination therapy has become the hallmark of lung cancer treatment, as it reduces the dosage intensity of individual drugs while increasing their efficacy. In the current study, we analyzed the combinatorial effect of decitabine and aspirin on non-small cell lung cancer (NSCLC) cell gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Maoyi, Song, Binbin, Yang, Xinmei, Li, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315258/
https://www.ncbi.nlm.nih.gov/pubmed/35869624
http://dx.doi.org/10.1177/03000605221112024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315258/
https://www.ncbi.nlm.nih.gov/pubmed/35869624
http://dx.doi.org/10.1177/03000605221112024

Ejemplares similares